- Product category
-
Viruses
- Product type
-
Animal virus
- Classification
- Pneumoviridae, Orthopneumovirus
- Strain designation
- 9320
- Isolation source
- This strain was isolated in 1977 from the throat swab of a 23-month-old human female with diffuse interstitial pneumonia in Massachusetts.
- Geographical isolation
- United States; Massachusetts
- Applications
-
Infectious disease researchRespiratory disease research
- Product format
- Frozen
- Storage conditions
-
-70°C or colder
Documentation
ATCC determines the biosafety level of a material based on our risk assessment as guided by the current edition of Biosafety in Microbiological and Biomedical Laboratories (BMBL), U.S. Department of Health and Human Services. It is your responsibility to understand the hazards associated with the material per your organization’s policies and procedures as well as any other applicable regulations as enforced by your local or national agencies.
ATCC highly recommends that appropriate personal protective equipment is always used when handling vials. For cultures that require storage in liquid nitrogen, it is important to note that some vials may leak when submersed in liquid nitrogen and will slowly fill with liquid nitrogen. Upon thawing, the conversion of the liquid nitrogen back to its gas phase may result in the vial exploding or blowing off its cap with dangerous force creating flying debris. Unless necessary, ATCC recommends that these cultures be stored in the vapor phase of liquid nitrogen rather than submersed in liquid nitrogen.
Detailed product information
General
- Specific applications
-
Respiratory research
Characteristics
- Comments
-
This strain belongs to subgroup B [PubmedID: 2579169]. Infection may be best achieved by co-cultivation with freshly trypsinized cells.
- Mycoplasma contamination
- Not detected
Handling information
- Host
-
HEp-2 (ATCC CCL-23)
- Effects
-
cell rounding; syncytia; cell sloughing; cell detachment
- Complete medium
-
EMEM (ATCC 30-2003) + 10% FBS (ATCC 30-2020)
- Temperature
-
37°C
- Atmosphere
-
95% Air, 5% CO2
- Incubation
- 3-7 days, a 5% CO2 in air atmosphere is recommended
- Recommendation for infection
-
- Seed cells at 4.0 – 5.0 x 104 cells/cm2 to achieve 70-80% confluence at the time of infection (1 – 2 days after seeding).
- Remove medium, rinse cell monolayer with 1XDPBS or neat DMEM. Inoculate with virus diluted in DMEM+1%FBS, with a virus MOI of 0.1.
- Adsorption for 2 – 2.5 hours at 37°C, 5% C02, humidity.
- AGM is DMEM + 1% FBS.
- Incubation is at 37°C, 5% C02, humidity. Recommended incubation time is 4 - 7 days.
- Harvest infection vessel at 70 – 90% CPE presentation
- Handling notes
-
This strain belongs to subgroup “B” according to Journal of Infectious Diseases 151: 626-633, 1985.
Published data from researchers and testing performed during ATCC accessioning have established that the HEp-2 cell line (ATCC CCL-23) is contaminated with HeLa cells.
ATCC confirmed that previous lots of CCL-23 cells have tested positive for Human Papillomavirus viral DNA sequences via PCR.
- Key abbreviations
-
°C, Degrees CelsiusCO2, Carbon dioxideEMEM, Eagle's Minimum Essential MediumFBS, Fetal bovine serumMOI, Multiplicity of infection
Quality control specifications
- Volume
- 1.0 mL
- Verification method
-
Whole-genome Sequencing
History
- Deposited as
- Respiratory syncytial virus
- Depositors
- M Hirsch, E Keller
- Type of isolate
- Human
- Year of origin
- 1977
- Patient age
- 23 months
- Patient sex
- Female
Legal disclaimers
- Intended use
- This product is intended for laboratory research use only. It is not intended for any animal or human therapeutic use, any human or animal consumption, or any diagnostic use.
- Warranty
-
The product is provided 'AS IS' and the viability of ATCC® products is warranted for 30 days from the date of shipment, provided that the customer has stored and handled the product according to the information included on the product information sheet, website, and Certificate of Analysis. For living cultures, ATCC lists the media formulation and reagents that have been found to be effective for the product. While other unspecified media and reagents may also produce satisfactory results, a change in the ATCC and/or depositor-recommended protocols may affect the recovery, growth, and/or function of the product. If an alternative medium formulation or reagent is used, the ATCC warranty for viability is no longer valid. Except as expressly set forth herein, no other warranties of any kind are provided, express or implied, including, but not limited to, any implied warranties of merchantability, fitness for a particular purpose, manufacture according to cGMP standards, typicality, safety, accuracy, and/or noninfringement.
- Disclaimers
-
This product is intended for laboratory research use only. It is not intended for any animal or human therapeutic use, any human or animal consumption, or any diagnostic use. Any proposed commercial use is prohibited without a license from ATCC.
While ATCC uses reasonable efforts to include accurate and up-to-date information on this product sheet, ATCC makes no warranties or representations as to its accuracy. Citations from scientific literature and patents are provided for informational purposes only. ATCC does not warrant that such information has been confirmed to be accurate or complete and the customer bears the sole responsibility of confirming the accuracy and completeness of any such information.
This product is sent on the condition that the customer is responsible for and assumes all risk and responsibility in connection with the receipt, handling, storage, disposal, and use of the ATCC product including without limitation taking all appropriate safety and handling precautions to minimize health or environmental risk. As a condition of receiving the material, the customer agrees that any activity undertaken with the ATCC product and any progeny or modifications will be conducted in compliance with all applicable laws, regulations, and guidelines. This product is provided 'AS IS' with no representations or warranties whatsoever except as expressly set forth herein and in no event shall ATCC, its parents, subsidiaries, directors, officers, agents, employees, assigns, successors, and affiliates be liable for indirect, special, incidental, or consequential damages of any kind in connection with or arising out of the customer's use of the product. While reasonable effort is made to ensure authenticity and reliability of materials on deposit, ATCC is not liable for damages arising from the misidentification or misrepresentation of such materials.
Please see the material transfer agreement (MTA) for further details regarding the use of this product. The MTA is available at www.atcc.org.
Images
Frequently Asked Questions
References
Curated Citations
Anderson LJ, et al. Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J. Infect. Dis. 151: 626-633, 1985. PubMed: 2579169
Hierholzer JC, Hirsch MS. Croup and pneumonia in human infants associated with a new strain of respiratory syncytial virus. J. Infect. Dis. 140: 826-828, 1979. PubMed: 119004
For product-related inquiries and issues, contact Product Experience:
Hours of Operation
US Eastern Time